A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3504-3513

  Sekulić, Aleksandar ^a   Hudson, Christine C ^c   Homme, James L ^b   Yin, Peng ^c   Otterness, Diane M ^c   Karnitz, Larry M ^a   Abraham, Robert T ^c  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; RAPAMYCIN; SERINE; THREONINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL TRANSFORMATION; CYTOSTASIS; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-3; KIDNEY; KINETICS; MAMMALS; MICE; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SIROLIMUS; TRANSFECTION;

EID: 0034234924     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. 1 events and the regulation of cell proliferation. Science (Washington DC), 246: 603-640, 1989.
2. Albers, M. W., Williams, R. T., Brown, E, J., Tanaka, A., Hall, F. L., and Schreiber, S. L. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. J. Biol. Chem., 268: 22825-22829, 1993.
3. Morice, W. G., Brunn, G. J., Wiederrecht, G., Siekierka, J. J., and Abraham, R. T. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. J. Biol. Chem., 268: 3734-3738, 1993.
4. Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., and Abraham, R. T. Isolation of a protein target of Ihe FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem., 270: 815-822, 1995.
5. Brown, E. J., Albers, M. W., Shin, T. B., Ichikawa, K., Keith, C. T., Lane, W. S., and Schreiber, S. L. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (Lond.), 369: 756-758, 1994.
6. Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., and Snyder, S. H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell, 78: 35-43, 1994.
7. Chiu, M. I., Katz, H., and Berlin, V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc. Natl. Acad. Sci. USA, 91: 12574-12578, 1994.
8. Abraham, R. T. Phosphoinositide 3-kinase related kinases. Curr. Opin. Immunol., 8: 412-418, 1996.
9. Heitman, J., Movva, N. R., and Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science (Washington DC), 253: 905-909, 1991.
10. Calvo, V., Crews, C. M., Vik, T. A., and Bierer, B. E. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc. Natl. Acad. Sci. USA, 89: 7571-7575, 1992.
11. Chung, J., Kuo, C. J., Crabtree, G. R., and Blenis, J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 Kd S6 protein kinases. Cell, 69: 1227-1236, 1992.
12. Kuo, C. J., Chung, J., Fiorentino, D. F., Flanagan, W. M., Blenis, J., and Crabtree, G. R. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature (Lond.), 358: 70-73, 1992.
13. Pearson, R. B., Dennis, P. B., Han, J. W., Williamson, N. A., Kozma, S. C., Wettenhall, R. E., and Thomas, G. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J., 14: 5279-5287, 1995.
14. Price, D., Grove, J., Calvo, V., Avruch, J., and Bierer, B. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science (Washington DC), 257: 973-977, 1992.
15. Jefferies, H. B., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., and Thomas, G. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J., 16: 3693-3704, 1997.
16. Jefferies, H. B., Reinhard, C., Kozma, S. C., and Thomas, G. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. USA, 91: 4441-4445, 1994.
17. Meyuhas, O., Avni, D., and Shama, S. Translational control of ribosomal protein mRNAs in eukaryotes. In: J. W. B. Hershey, M. B. Mathews, and N. Sonenberg (eds.), Translational Control, pp. 363-388. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1996.
18. Alessi, D. R., Kozlowski, M. T., Weng, Q. P., Morrice, N., and Avruch, J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol., 8: 69-81, 1998.
19. Proud, C. G. p70 S6 kinase: an enigma with variations. Trends Biochem. Sci., 21: 181-185, 1996.
20. Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A., and Thomas, G. Phosphorylation and activation of p70s6k by PDK1. Science (Washington DC), 279: 707-710, 1998.
21. Pullen, N., and Thomas, G. The modular phosphorylation and activation of p70s6k. FEBS Lett., 410: 78-82, 1997.
22. Peterson, R. T., Desai, B. N., Hardwick, J. S., and Schreiber, S. L. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin-assodated protein. Proc. Natl. Acad. Sci. USA. 96: 4438-4442, 1999.
23. Sonenberg, N., and Gingras, A. C. The mRNA 5′ cap-binding protein elF4E and control of cell growth. Curr. Opin. Cell Biol., 10: 268-275, 1998.
24. Aronica, S. M., Gingras, A. C., Sonenberg, N., Cooper, S., Hague, N., and Broxmeyer, H. E. Macrophage inflammatory protein-1α and interferon-inducible protein 10 inhibit synergistically induced growth factor stimulation of MAP kinase activity and suppress phosphorylation of eukaryotic initiation factor 4E and 4E binding protein 1. Blood, 89: 3582-3595, 1997.
25. Fadden, P., Haystead, T. A., and Lawrence, J. C., Jr. Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. J. Biol. Chem., 272: 10240-10247, 1997.
26. Fleurent, M., Gingras, A. C., Sonenberg, N., and Meloche, S. Angiotensin II stimulates phosphorylation of the translational repressor 4E-binding protein 1 by a mitogen-activated protein kinase-independent mechanism. J. Biol. Chem., 272: 4006-4012, 1997.
27. Graves, L. M., Bornfeldt, K. E., Argast, G. M., Krebs, E. G., Kong, X., Lin, T. A., and Lawrence, J. C., Jr. cAMP-and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA, 92: 7222-7226, 1995.
28. Kleijn, M., Voorma, H. O., and Thomas, A. A. Phosphorylation of eIF-4E and initiation of protein synthesis in P19 embryonal carcinoma cells. J. Cell. Biochem., 59, 443-452, 1995.
29. Pause, A., Belsham, G. J., Gingras, A. C., Donze, O., Lin, T. A., Lawrence, J. C., Jr., and Sonenherg, N. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature (Lond.), 371: 762-767, 1994.
30. Beretta, L., Gingras, A. C., Svitkin, Y. V., Hall, M. N., and Sonenberg, N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J., 15: 658-664, 1996.
31. Lin, T. A., Kong, X., Saltiel, A. R., Blackshear, P. J., and Lawrence, J. C., Jr. Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. J. Biol. Chem., 270: 18531-18538, 1995.
32. Brunn, G. J., Hudson, C., C., Sekulić, A., Williams, J. M., Hosoi, J., Houghton, P. J., Lawrence, J. C., and Abraham, R. T. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science (Washington DC), 277: 99-101, 1997.
33. Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., and Sabatini, D. M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA, 95: 1432-1437, 1998.
34. Gingras, A. C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., and Sonenberg, N. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev., 13: 1422-1437, 1999.
35. Gingras, A. C., Kennedy, S. G., O'Leary, M. A., Sonenberg, N., and Hay, N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Dev., 12: 502-513, 1998.
36. Maehama, T., and Dixon, J. E. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell. Biol., 9: 125-128, 1999.
37. Cantley, L. C., and Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway. Proc. Natl. Acad. Sci. USA, 96: 4240-4245, 1999.
38. Brunn, G. J., Fadden, P., Haystead, T. A. J., and Lawrence, J. C., Jr. The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus. J. Biol. Chem., 272: 32547-32550, 1997.
39. Scott, P. H., Brunn, G. J., Kohn, A. D., Roth, R. A., and Lawrence, J. C. Evidence of insulin-stimulated phosphorylation and activation of mammalian target of rapamycin by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA, 95: 7772-7777, 1998.
40. Horton, R. M., Ho, S. N., Pullen, J. K., Hunt, H. D., Cai, Z., and Pease, L. R. Gene splicing by overlap extension. Methods Enzymol., 217: 270-279, 1993.
41. de Groot, R. P., Coffer, P. J., and Koenderman, L. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cellular Signalling, 10: 619-628, 1998.
42. Karnitz, L. M., Burns, L. A., Sutor, S. L., Blenis, J., and Abraham, R. T. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol., 15: 3049-3057, 1995.
43. Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., and Schreiber, S. L. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature (Lond.), 377: 441-446, 1995.
44. Brunn, G. J., Williams, J., Sabers, C., Wiederrecht, G., Lawrence, J. C., Jr., and Abraham, R. T. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J., 15: 5256-5267, 1996.
45. Nakatani, K., Thompson, D. A., Barthel, A., Sakaue, H., Liu, W., Weigel, R. J., and Roth, R. A. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J. Biol. Chem., 274: 21528-21532, 1999.
46. Nave, B. T., Ouwens, D. M., Withers, D. J., Alessi, D. R., and Shepherd, P. R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J., 344: 427-431, 1999.
47. Parekh, D., Ziegler, W., Yonezawa, K., Hara, K., and Parker, P. J. Mammalian TOR controls one of two kinase pathways acting upon nPKC delta and nPKC epsilon. J. Biol. Chem., 274: 34758-34764, 1999.
48. Mischak, H., Goodnight, J. A., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H., and Mushinski, J. F. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem., 268: 6090-6096, 1993.
49. Kiley, S. C., Clark, K. J., Duddy, S. K., Welch, D. R., and Jaken, S. Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene, 18: 6748-6757, 1999.
50. Shi, Y., Frankel, A., Radvanyi, L. G., Penn, L. Z., Miller, R. G., and Mills, G. B. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res., 55: 1982-1988, 1995.
51. Klippel, A., Escobedo, M. A., Wachowicz, M. S., Apell, G., Brown, T. W., Giedlin, M. A., Kavanaugh, W. M., and Williams, L. T. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol., 18: 5699-5711, 1998.